Callan Family Office LLC Buys Shares of 6,367 Exelon Co. (NASDAQ:EXC)

Callan Family Office LLC bought a new stake in Exelon Co. (NASDAQ:EXC) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 6,367 shares of the company’s stock, valued at approximately $240,000.

Several other hedge funds have also recently made changes to their positions in the company. State Street Corp raised its stake in shares of Exelon by 3.7% during the 3rd quarter. State Street Corp now owns 60,169,219 shares of the company’s stock valued at $2,439,862,000 after purchasing an additional 2,156,259 shares during the period. Geode Capital Management LLC raised its stake in shares of Exelon by 1.6% during the 3rd quarter. Geode Capital Management LLC now owns 25,945,791 shares of the company’s stock valued at $1,048,823,000 after purchasing an additional 403,542 shares during the period. FMR LLC raised its stake in shares of Exelon by 18.7% during the 3rd quarter. FMR LLC now owns 11,782,549 shares of the company’s stock valued at $477,782,000 after purchasing an additional 1,858,502 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in shares of Exelon by 1.8% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,967,343 shares of the company’s stock valued at $363,626,000 after purchasing an additional 160,313 shares during the period. Finally, Charles Schwab Investment Management Inc. raised its stake in shares of Exelon by 4.4% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 6,729,004 shares of the company’s stock valued at $253,280,000 after purchasing an additional 282,596 shares during the period. 80.92% of the stock is currently owned by institutional investors.

Exelon Price Performance

Shares of Exelon stock opened at $43.40 on Wednesday. The company has a current ratio of 0.87, a quick ratio of 0.78 and a debt-to-equity ratio of 1.61. The firm has a market capitalization of $43.63 billion, a PE ratio of 17.71, a price-to-earnings-growth ratio of 2.86 and a beta of 0.51. The business’s 50-day moving average price is $40.98 and its 200-day moving average price is $39.64. Exelon Co. has a 12 month low of $34.01 and a 12 month high of $45.19.

Exelon (NASDAQ:EXC) last announced its quarterly earnings data on Wednesday, February 12th. The company reported $0.64 EPS for the quarter, beating the consensus estimate of $0.59 by $0.05. Exelon had a return on equity of 9.52% and a net margin of 10.68%. During the same quarter last year, the firm posted $0.60 EPS. Sell-side analysts forecast that Exelon Co. will post 2.64 EPS for the current fiscal year.

Exelon Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 14th. Stockholders of record on Monday, February 24th will be given a dividend of $0.40 per share. The ex-dividend date is Monday, February 24th. This is a positive change from Exelon’s previous quarterly dividend of $0.38. This represents a $1.60 annualized dividend and a dividend yield of 3.69%. Exelon’s dividend payout ratio is 65.31%.

Insider Activity

In related news, EVP Colette D. Honorable sold 1,463 shares of the firm’s stock in a transaction that occurred on Monday, February 3rd. The stock was sold at an average price of $40.57, for a total transaction of $59,353.91. Following the transaction, the executive vice president now directly owns 2,271 shares in the company, valued at $92,134.47. This trade represents a 39.18 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 0.10% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on EXC shares. Morgan Stanley decreased their price objective on Exelon from $46.00 to $44.00 and set an “equal weight” rating on the stock in a research note on Friday, November 22nd. BMO Capital Markets restated an “outperform” rating on shares of Exelon in a research report on Tuesday, February 4th. Scotiabank boosted their target price on Exelon from $42.00 to $44.00 and gave the stock a “sector perform” rating in a research report on Thursday, February 13th. Guggenheim upgraded Exelon from a “neutral” rating to a “buy” rating in a research report on Thursday, January 23rd. Finally, Barclays boosted their target price on Exelon from $42.00 to $48.00 and gave the stock an “overweight” rating in a research report on Tuesday, February 25th. Five equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $44.13.

Exelon Profile

Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.